Junior Faculty Presentation
Dual PI3K/BRS4 Inhibition as a Novel Therapeutic Strategy for Hepatocellular Carcinoma
Adam Burgoyne, MD, PhD UC San Diego Moores Cancer Center
Adam Burgoyne, MD, PhD Instructor of Medicine
Division of Hematology/Oncology, Department of Medicine
UC San Diego Moores Cancer Center
Dr. Adam Burgoyne is an Instructor of Medicine in the Division of Hematology/Oncology at the UC San Diego Moores Cancer Center. He is a medical oncologist specializing in the treatment of gastrointestinal and hepatobiliary tumors. He received his medical and graduate degrees from Case Western Reserve University School of Medicine and completed his internal medicine residency and hematology/oncology fellowship at UC San Diego Medical Center, where he served as Chief Fellow. He is a physician-scientist with research interests including characterization of the tumor microenvironment of gastrointestinal stromal tumors and rational drug design of targeted therapeutics for personalized therapy of hepatocellular carcinoma.